SpineOvations

SpineOvations is a clinical-stage medical device company dedicated to developing minimally invasive treatments for chronic discogenic back pain. The company's flagship technology, Disc-Seal, is a proprietary, radiopaque, synthetic polymer gel designed to be injected percutaneously into the lumbar intervertebral disc. This "internal bandage" seals disc tears and reinforces the disc structure, aiming to alleviate pain without the need for invasive surgery like spinal fusion. SpineOvations targets patients with degenerative disc disease who have not responded to conservative care but are not yet candidates for major surgical intervention. Headquartered in Newport Beach, California, the company is advancing its clinical trials to provide a safer, more cost-effective solution for the millions suffering from chronic back pain.